Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-090655

Options or other derivatives

  • Chief Executive Officer acquired 1,968,016 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Noble James Chief Executive Officer 2016-01-18 Grant or award · Option to purchase Ordinary Shares +1,968,016 1,968,016 D: show line 1 in the form
Loading xslF345X03/a4.xml…